Your browser doesn't support javascript.
loading
The progression rate of aortic stenosis: key to tailoring the management and potential target for treatment.
Tafciu, Elvin; Mandoli, Giulia E; Santoro, Ciro; Setti, Martina; d'Andrea, Antonello; Esposito, Roberta; Bandera, Francesco; Evola, Vincenzo; Malagoli, Alessandro; Cameli, Matteo; Benfari, Giovanni.
Afiliação
  • Tafciu E; Department of Cardiology, University of Verona, Verona.
  • Mandoli GE; Department of Cardiology, University of Siena, Siena.
  • Santoro C; Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples.
  • Setti M; Department of Cardiology, University of Verona, Verona.
  • d'Andrea A; Department of Cardiology, Umberto I Hospital, Luigi Vanvitelli University, Nocera Inferiore (Salerno).
  • Esposito R; Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples.
  • Bandera F; Department of University Cardiology, IRCCS Policlinico San Donato, San Donato Milanese.
  • Evola V; Department of Clinical and Experimental Medicine, University of Palermo, Palermo.
  • Malagoli A; Division of Cardiology, Nephro-Cardiovascular Department, "S. Agostino-Estense" Public Hospital, University of Modena and Reggio Emilia, Modena, Italy.
  • Cameli M; Department of Cardiology, University of Siena, Siena.
  • Benfari G; Department of Cardiology, University of Verona, Verona.
J Cardiovasc Med (Hagerstown) ; 22(11): 806-812, 2021 Nov 01.
Article em En | MEDLINE | ID: mdl-33136810
ABSTRACT
Aortic stenosis is the most frequent valvular disease to require intervention in the western world and has always been featured as a progressive disease. The rate of progression can be assessed by carefully performed Doppler echocardiography and can vary greatly between individuals with a profound impact on prognosis. Unfortunately, the determinants of disease progression had been insufficiently studied and remain challenging to define, particularly in the outpatient setting. Multiple factors have been proposed and tested, but at present, there are no proven therapies to slow the course of the stenotic process. Heart valve clinics may be particularly important to define the progression rate and tailor follow-up and management at an individual level. This review enlightens knowledge and gaps regarding the progression-rate of aortic valve stenosis, from the historical perspective to the molecular one.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Med (Hagerstown) Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Med (Hagerstown) Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2021 Tipo de documento: Article